ID | 118965 |
Title Alternative | FTF in Anti-VEGF Treatment for BRVO
|
Author |
Nagasato, Daisuke
Saneikai Tsukazaki Hospital|Hiroshima University|Tokushima University
Muraoka, Yuki
Kyoto University
Tanabe, Mao
Saneikai Tsukazaki Hospital
Nishigori, Naomi
Kyoto University
Osaka, Rie
Kagawa University
Mitamura, Yoshinori
Tokushima University
Tokushima University Educator and Researcher Directory
KAKEN Search Researchers
Tabuchi, Hitoshi
Saneikai Tsukazaki Hospital|Hiroshima University|Tokushima University
Kadomoto, Shin
Kyoto University
Murakami, Tomoaki
Kyoto University
Ooto, Sotaro
Kyoto University
Suzuma, Kiyoshi
Kagawa University
Tsujikawa, Akitaka
Kyoto University
|
Keywords | A long-term multicenter study
Anti-VEGF treatment
Branch retinal vein occlusion
Foveal thickness fluctuation
|
Content Type |
Journal Article
|
Description | Purpose: Branch retinal vein occlusion (BRVO) causes macular edema (ME), which can be controlled with anti-VEGF treatments. However, these treatments are not curative, necessitating additional anti-VEGF treatments at recurrence. Long-term results, optimal anti-VEGF treatment regimens, and the comprehensive effects of ME recurrence are largely unknown. Thus, we aimed to examine the effects of foveal thickness (FT) fluctuation (FTF) on the visual and morphologic outcomes of anti-VEGF treatments for BRVO-ME administered via a pro re nata regimen.
Design: A retrospective, observational case series. Subjects: This study analyzed 309 treatment-naïve patients (309 eyes) with BRVO-ME between 2012 and 2021 at a multicenter retinal practice. Methods: The FT was assessed using OCT at each study visit. Main Outcome Measures: We evaluated the logarithm of the minimal angle of resolution (logMAR) best corrected visual acuity (BCVA) and the defect length of the foveal ellipsoid zone (EZ) band using OCT. Results: At baseline, the mean logMAR BCVA was 0.30 ± 0.30 and the mean FT was 503 ± 162 μm. The number of anti-VEGF injections for BRVO-ME was 5.8 ± 4.6 during the mean follow-up period (50.6 ± 22.2 months). At the final examination, the mean logMAR BCVA and FT values were significantly improved compared with those at the baseline. Multiple regression analyses showed that age, baseline logMAR BCVA, and FTF were significantly associated with the final logMAR BCVA (β = 0.20, 0.35, and 0.30, respectively). Foveal thickness fluctuation (divided into groups 0–3 in ascending order of FTF) was significantly associated with logMAR BCVA and the defect length of the foveal EZ band at the final examination. The defect lengths of the foveal EZ band were longitudinally shortened in groups 0 and 1 and were slightly prolonged in groups 2 and 3. The logMAR BCVA showed improvements in groups 0 and 1 and worsened slightly in groups 2 and 3. Conclusions: Foveal thickness fluctuation was significantly associated with visual acuity and foveal photoreceptor status. Thus, the morphologic and functional prognoses of eyes with BRVO may improve with the identification of the characteristics of eyes with greater FTF and consequently controlling the FTF more strictly. |
Journal Title |
Ophthalmology Retina
|
ISSN | 24686530
24687219
|
Publisher | Elsevier
|
Volume | 6
|
Issue | 7
|
Start Page | 567
|
End Page | 574
|
Published Date | 2022-02-24
|
Rights | This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
|
EDB ID | |
DOI (Published Version) | |
URL ( Publisher's Version ) | |
FullText File | |
language |
eng
|
TextVersion |
Publisher
|
departments |
Medical Sciences
|